Leica Optical Coherence Tomography (OCT) systems support ophthalmologists, ophthalmic surgeons, and researchers with easy-to-use, high-quality imaging technology. The preclinical OCT solutions provide insight into eye disease research, while the clinical OCT systems serve as an aid in diagnosing pathological conditions. Each system is non-invasive, contact-free, and helps detect and monitor morphological changes of ocular tissue.
OCT from Leica Microsystems
With the acquisition of Bioptigen in 2015, Leica Microsystems offers OCT imaging systems for clinical ophthalmology and preclinical research.
Contact a local specialist for expert advice on the right OCT solution for your needs and budget.
Perioperative OCT provides anatomic feedback to the surgeon, which aids in the visualization of physiological and pathological conditions during ophthalmic surgery, and helps guide surgical decision making in anterior as well as posterior cases.
Our product solution: EnFocusTM
Bioptigen’s OCT systems have revolutionized the clinical practice of ophthalmology by providing high-resolution images, ultra-fast scanning, and deep insight into anatomic information. It has become the gold standard imaging modality for many conditions for aiding in the diagnosis and monitoring of therapeutic outcomes, and has quickly become one of the most frequently ordered diagnostic tests in all of medicine. The Envisu C2300 is the world’s only handheld FDA-cleared OCT system for aiding in the diagnosis of eye disease.
Our product solution: Envisu C-Class
Join the Paediatric OCT Course, Nov 30th – Dec 1st, 2017, hosted by the University of Leicester
Leica Microsystems introduces the EnFocus intrasurgical OCT system in combination with the Proveo 8 surgical microscope to enhance ophthalmic surgical visualization
New ophthalmology case study on Science Lab: Videos captured with EnFocus intrasurgical OCT demonstrate how visualization of the membrane can impact the surgical process of membrane peeling
Frost & Sullivan recognizes subsidiary Bioptigen for their product innovation in OCT
Leica Microsystems’ subsidiary Bioptigen receives FDA’s 510(k) clearance for EnFocus
The PIONEER Study Two-year Results and Beyond
This article published in the journal OSLI Retina discusses the findings of the latest phase of the DISCOVER study relating specifically to the…
When treating patients with vitreomacular traction (VMT), peeling of the inner limiting membrane (ILM) or an epiretinal membrane (ERM) is often…
Optical Coherence Tomography (OCT) is a non-invasive, non-contact imaging modality used to visualize and monitor changes to the morphology of…